Jesse E. Gary Sells 15,244 Shares of Century Aluminum Co (NASDAQ:CENX) Stock

Share on StockTwits

Century Aluminum Co (NASDAQ:CENX) COO Jesse E. Gary sold 15,244 shares of the stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $8.36, for a total transaction of $127,439.84. Following the completion of the sale, the chief operating officer now owns 109,077 shares in the company, valued at approximately $911,883.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

NASDAQ:CENX opened at $8.28 on Friday. Century Aluminum Co has a 1-year low of $5.02 and a 1-year high of $9.98. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.45 and a quick ratio of 0.79. The company’s fifty day moving average price is $6.53 and its 200-day moving average price is $6.68. The firm has a market capitalization of $626.70 million, a P/E ratio of -59.14 and a beta of 1.89.

Century Aluminum (NASDAQ:CENX) last released its quarterly earnings data on Tuesday, November 5th. The industrial products company reported ($0.39) EPS for the quarter, missing the consensus estimate of ($0.30) by ($0.09). Century Aluminum had a negative return on equity of 21.94% and a negative net margin of 7.47%. The business had revenue of $438.00 million during the quarter, compared to analysts’ expectations of $459.07 million. During the same quarter in the prior year, the firm earned $0.02 earnings per share. Century Aluminum’s quarterly revenue was down 9.1% on a year-over-year basis. Equities analysts anticipate that Century Aluminum Co will post -1.27 EPS for the current fiscal year.

A number of analysts have recently weighed in on CENX shares. BidaskClub upgraded shares of Century Aluminum from a “hold” rating to a “buy” rating in a research note on Saturday. BMO Capital Markets increased their price objective on shares of Century Aluminum from $7.00 to $9.00 and gave the stock an “outperform” rating in a research note on Wednesday. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus target price of $10.40.

Institutional investors have recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC boosted its position in shares of Century Aluminum by 1,471.5% in the 3rd quarter. Tower Research Capital LLC TRC now owns 7,512 shares of the industrial products company’s stock worth $49,000 after buying an additional 7,034 shares in the last quarter. Tyers Asset Management LLC lifted its holdings in Century Aluminum by 27.8% in the 2nd quarter. Tyers Asset Management LLC now owns 8,912 shares of the industrial products company’s stock valued at $62,000 after purchasing an additional 1,936 shares in the last quarter. Ellington Management Group LLC purchased a new position in Century Aluminum in the 2nd quarter valued at about $74,000. Elkfork Partners LLC lifted its holdings in Century Aluminum by 27.8% in the 2nd quarter. Elkfork Partners LLC now owns 12,254 shares of the industrial products company’s stock valued at $85,000 after purchasing an additional 2,662 shares in the last quarter. Finally, First Republic Investment Management Inc. purchased a new position in Century Aluminum in the 2nd quarter valued at about $104,000. Institutional investors and hedge funds own 53.92% of the company’s stock.

About Century Aluminum

Century Aluminum Company, together with its subsidiaries, produces standard-grade and value-added primary aluminum products in the United States and Iceland. The company was founded in 1995 and is headquartered in Chicago, Illinois.

Read More: Can systematic risk be avoided?

Receive News & Ratings for Century Aluminum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Century Aluminum and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.